Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

OriGene Launches Genome-wide Gene-knockout Kits Using CRISPR Platform

Published: Thursday, May 08, 2014
Last Updated: Thursday, May 08, 2014
Bookmark and Share
A complete solution to knock out a human gene at the chromosomal level.

OriGene Technologies has launched a new product line of gene-knockout kits using CRISPR technologies. The new products provide a complete solution for researchers to knock out a human gene at the chromosomal level. This genome wide offering provides an unprecedented convenience for genome editing using the CRISPR technology.

OriGene has always been focused on providing reagents of highest quality. Its comprehensive offering of expression cDNA clones, shRNA/siRNA, recombinant proteins and antibodies are widely utilized in the biomedical research community world-wide and are cited in thousands of publications.

“CRISPR is a revolutionary tool for biomedical scientists. Our dream of a pair of simple accurate molecular scissor is now a reality. As the world’s largest supplier of molecular tools, OriGene is excited to be in the middle of this technology boom. Launching genome-wide knock-out kits is only the very first step for OriGene to help harness the power of the CRISPR technology.” said Dr. Wei-Wu He, CEO and Chairman of OriGene.

“An established leader in the molecular biology market, especially utilizing its US-based gene-synthesis capacity, OriGene is in a perfect position to provide genome wide CRISPR tools to the research community.” Remarked Dr. Youmin Shu, SVP of Molecular Biology.

Dr. Shu continued, “We provide a kit against every human gene locus, containing 2 gRNAs and a compatible donor vector with a functional cassette. In additional to gene knockout, this kit can also be used for promoter strength study for each gene locus. The pre-designed nature of the kit greatly reduces the researcher’s time and effort using this great platform.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

OriGene Awarded Contract to Develop Monoclonal Antibodies for SISCAPA
OriGene Technologies have announced that they have been awarded a Phase II SBIR contract from the National Cancer Institute (NCI) to develop high-affinity, anti-peptide antibodies for mass-spectrometry-based serum biomarker detection/ quantification assays.
Monday, January 11, 2016
OriGene Awarded NCI Contract
The contract will see OriGene to develop high affinity anti-peptide antibodies for SISCAPA assays.
Monday, February 03, 2014
OriGene Technologies Announces the Acquisition of ZsBio
Acquisition establishes OriGene's leading position in the Chinese pathology testing market.
Tuesday, March 13, 2012
OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
Extensively validated monoclonal antibodies made against native protein antigens for superior IHC, IF, ELISA and flow applications.
Monday, January 24, 2011
OriGene Technologies Acquires Blue Heron Biotechnology
OriGene’s collection of human cDNA clones together with Blue Heron’s gene synthesis capacity provides a whole product solution for the life sciences community.
Tuesday, August 17, 2010
Scientific News
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Genetic Cause of Rare Allergy
Institute has identified a genetic mutation responsible for a rare form of inherited hives induced by vibratory urticaria.
Battery Component Found to Harm Key Soil Microorganism
The material at the heart of the lithium ion batteries that power electric vehicles, laptop computers and smartphones has been shown to impair a key soil bacterium, according to new research.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Mitochondria Shown to Trigger Cell Ageing
An international team of scientists has for the first time shown that mitochondria, the batteries of the cells, are essential for ageing.
Cancer Cells Kill Off Healthy Neighbours
Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.
Validating the Accuracy of CRISPR-Cas9
IBS Researchers create multiplex Digenome-seq to find errors in CRISPR-Cas9 processes.
Cancer Drug Target Visualized at Atomic Resolution
New study using cryo-electron microscopy shows how potential drugs could inhibit cancer.
Genetic Mechanism Behind Cancer-Causing Mutations
Researchers at Indiana University has identified a genetic mechanism that is likely to drive mutations that can lead to cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!